Characterization of KIF20B as a Novel Prognostic Biomarker and Therapeutic Target for Breast Cancer

Using reverse transcription‑quantitative PCR and western blotting, investigators discovered that kinesin family member 20B (KIF20B) mRNA and protein expression levels were upregulated in most breast cancer cell lines but were scarcely expressed in normal mammary epithelial cells.